Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies

Condition:   Centronuclear Myopathy Intervention:   Drug: DYN101 Sponsor:   Dynacure Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials